<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter/><pubmed_abstract>&lt;h4>Background:&lt;/h4> Systemic sclerosis (SSc) is an autoimmune disease characterized by vasospasm</pubmed_abstract><journal>Therapeutic advances in musculoskeletal disease</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9685102</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis</pubmed_title><pmcid>PMC9685102</pmcid></additional><is_claimable>false</is_claimable><name>Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis</name><description>&lt;h4>Background:&lt;/h4> Systemic sclerosis (SSc) is an autoimmune disease characterized by vasospasm</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2024-11-20T23:32:29.346Z</modification><creation>2024-11-20T23:32:29.346Z</creation></dates><accession>S-EPMC9685102</accession><cross_references/></HashMap>